Fulminant meningococcemia in children.
In all respects, the child with fulminant meningococcemia presents a formidable challenge to those who care for him/her. Only with prompt recognition of the disease and immediate institution of intensive treatment can the likelihood of survival be improved and morbidity minimized.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008589:Meningococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D009270:Naloxone / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D010956:Plasmapheresis; D011379:Prognosis; D018805:Sepsis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D013256:Steroids / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002317:Cardiovascular Agents; D013256:Steroids; D009270:Naloxone; D002701:Chloramphenicol; D010400:Penicillin G